Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 3,090.00
+20.00 (0.65%)
At close: Jun 30, 2026
Progen Market Cap
Progen has a market cap or net worth of 47.51 billion as of June 30, 2026. Its market cap has decreased by -54.33% in one year.
Market Cap
47.51B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,090.00
Market Cap Chart
Since November 15, 2023, Progen's market cap has increased from 46.33B to 47.51B, an increase of 2.55%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 47.51B | -59.02% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 59.45B |
| PanGen Biotech | 58.52B |
| KoBioLabs | 56.90B |
| IMGT Co.,Ltd. | 56.24B |
| EyeGene | 55.33B |
| TegoScience | 52.12B |
| Psomagen | 46.36B |
| Parataxis Korea | 44.13B |